Nexera Pharma announced that, due to partial share cancellation based on the RSU system, there has been a change in the number of issued shares and total amount. This adjustment resulted from some allotment recipients losing rights, which may impact future share issuance plans.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4565","jir_company_name":"Nexera Pharma Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-05-19","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4565-20260519-01.pdf","jir_short_summary":"Nexera Pharma announced that, due to partial share cancellation based on the RSU system, there has been a change in the number of issued shares and total amount. This adjustment resulted from some allotment recipients losing rights, which may impact future share issuance plans.","jir_summary":"### Overview of Capital Policy\nNexera Pharma announced that, regarding the new share issuance based on the RSU system, the number of issued shares and total amount were adjusted due to partial cancellation. Some recipients of the 18th and 20th RSU allocations lost rights, leading to changes in issued shares and total amount. This may affect shareholder dilution and shareholder value.\n\n### Future Outlook and Impact on Shareholders\nThis adjustment resulted from the loss of rights by some allocation recipients and may influence future share issuance plans and shareholder value. Nexera Pharma continues to pursue growth strategies and capital policies cautiously, providing transparent information to investors.","jir_financial_highlights":"Number of Issued Shares: After Change: 736,190 shares (Increase from previous)\nTotal Issue Amount: After Change: \u00a5526,806,825 (Increase)\nPayment Due Date: May 18, 2026 (No change)","jir_category":"","jir_hashtags":"#NexeraPharma, #share_cancellation, #JapanStocks","jir_key_figures":"Number of Issued Shares: 736,190 shares (after change)\nTotal Issue Amount: \u00a5526,806,825 (after change)\nPayment Due Date: May 18, 2026","jir_meta_title":"[Nexera Pharma] Notification of Partial Share Cancellation\uff5cMay 2026","jir_meta_description":"Nexera Pharma announced that, due to partial share cancellation based on the RSU system, the number of issued shares and total amount have been adjusted. This article explains the details of the adjustment and its future impact.","jir_og_title":"[Nexera Pharma] Notification of Partial Share Cancellation\uff5cMay 2026","jir_og_description":"Nexera Pharma has announced partial cancellation of new share issuance based on the RSU system. We explain the adjustment details of share count and total amount, as well as future prospects.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16880,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_cancellation","footnotes":""},"sector":[],"importance":[],"class_list":["post-52743","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n